Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety

JAMA Psychiatry. 2024 Jun 1;81(6):633-634. doi: 10.1001/jamapsychiatry.2024.0420.

Authors

Eiko I Fried¹, Ioana A Cristea², Florian Naudet³

Affiliations

¹ Department of Psychology, Clinical Psychology Unit, Leiden University, Leiden, the Netherlands.
² Department of General Psychology, University of Padova, Padova, Italy.
³ University of Rennes, University Hospital of Rennes, Inserm, Institut de recherche en santé, environnement et travail, Rennes, France.

PMID: 38598200
DOI: 10.1001/jamapsychiatry.2024.0420

No abstract available

MeSH terms

Bipolar Disorder* / drug therapy
Hallucinogens* / adverse effects
Hallucinogens* / therapeutic use
Humans
Psilocybin* / adverse effects
Psilocybin* / pharmacology
Psilocybin* / therapeutic use
Reproducibility of Results
Treatment Outcome

Substances

Psilocybin
Hallucinogens